HCPCS Level IIdrugActive
J0584
Injection, burosumab-twza 1m
BETOS: O1E
Effective: 2019-01-01
Referenced in 1 policies
Description
Injection, burosumab-twza 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Crysvita
Manufacturer
Kyowa Kirin, Inc.
HCPCS Dosage
1 MG
Billing Units
10.0000
3
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.